HeartSciences Inc., was incorporated in Texas in August 2007. They are a medical technology company focused on applying innovative artificial intelligence-based technologies to electrocardiograms to expand and improve the clinical usefulness of electrocardiograms. Their goal is to make ECG a more valuable cardiac screening tool, especially in front-line or bedside clinical settings. HeartSciences' first FDA-approved product candidate, MyoVistawavECG, is a resting 12-lead electrocardiogram that is also designed to provide diagnostic information related to cardiac dysfunction traditionally only available through the use of cardiac imaging. 

HSCS

HSCS Profile